Morepen Share Price Target Tomorrow From 2025 To 2030- Current Chart, Market Overview

Morepen Laboratories is a well-known Indian healthcare and pharmaceutical company trusted by millions. It offers a wide range of products—from quality medicines and active pharmaceutical ingredients (APIs) to home health devices like BP monitors, thermometers, and glucose meters. Morepen Share Price on NSE as of 05 June 2025 is 63.99 INR. This article will provide more details on Morepen Share Price Target 2025, 2026 to 2030.

Morepen Laboratories Ltd: Company Info

• Founded: 1984
  
• Headquarters: New Delhi
  
• Number of employees: 2,152 (2024)
  
• Subsidiaries: Doctor Morepen Limited, Morepen Inc.

Morepen Share Price Chart

Morepen Share: Market Overview

• Open: 64.70
• High: 64.92
• Low: 62.66
• Mkt cap: 3.50KCr
• P/E ratio: 29.09
• Div yield: N/A
• 52-wk high: 100.90
• 52-wk low: 42.00

Morepen Share Price Target Tomorrow From 2025 To 2030

Here are the estimated share prices of Morepen for the upcoming years, based solely on market valuation, enterprise trends and professional predictions.

• 2025 – ₹101
• 2026 – ₹120
• 2027 – ₹140
• 2028 – ₹160
• 2029 – ₹180
• 2030 – ₹200

Morepen Share Price Target 2025

Morepen share price target 2025 Expected target could be between ₹98 to ₹101. Here are 7 key factors affecting the growth of Morepen Laboratories’ share price target for 2025:

• Strong Demand for API and Pharma Products
  Morepen manufactures active pharmaceutical ingredients (APIs) and medicines. Growing demand for these boosts its sales and revenue.

• Export Opportunities
  Increasing global demand for affordable Indian medicines and APIs opens up more export markets for Morepen.

• Expansion of Healthcare Awareness
  Rising health awareness, especially post-COVID, supports more demand for diagnostic kits and wellness products by the company.

• Growth in Diagnostic Segment
  Morepen’s focus on home healthcare products like glucose monitors and oximeters adds to revenue from the fast-growing diagnostics market.

• R&D and New Product Launches
  Investing in research and launching innovative healthcare and wellness products helps attract new customers and improve margins.

• Government Support for Pharma Sector
  Incentives, policy support, and “Make in India” initiatives for the pharmaceutical sector benefit companies like Morepen.

• Strategic Collaborations and Partnerships
  Collaborations with global pharmaceutical firms or local distributors can enhance market presence and increase business volume.

Morepen Share Price Target 2030

Morepen share price target 2030 Expected target could be between ₹195 to ₹200. Here are 7 key risks and challenges that could impact Morepen Laboratories’ share price target by 2030:

• High Competition in Pharma Industry
  The pharmaceutical market is very competitive. Pressure from global and local rivals may affect market share and pricing.

• Regulatory and Compliance Risks
  Stricter drug regulations in India and abroad (like USFDA approvals) could delay product launches or lead to penalties.

• Raw Material Price Fluctuations
  Rising costs of key ingredients (APIs or chemicals) can reduce profit margins if not managed properly.

• Dependence on Few Key Products
  Heavy reliance on limited drugs or product lines can be risky if demand drops or competition increases.

• Foreign Exchange and Export Risks
  Since a part of Morepen’s revenue comes from exports, fluctuations in currency or changes in global trade policies can affect earnings.

• R&D Failure or Delays
  If research and development projects do not succeed or face delays, it could impact future growth and innovation.

• Market Sentiment and Stock Volatility
  Being a small-cap stock, Morepen’s share price can be more sensitive to market mood, news, or investor speculation.

Shareholding Pattern For Morepen Share

Morepen Financials

Read Also:- GTL Share Share Price Target Tomorrow From 2025 To 2030- Market Overview, Financials